Insights from 2023 ASCO® Annual Meeting
K

ASCO® 2023 Insights: "Biomarker Analysis of 2 Zolbetuximab Phase 3 Studies (SPOTLIGHT & GLOW) - Global Prevalence of CLDN18.2 in Locally Advanced Unresectable/Metastatic Gastric/GEJ Adenocarcinoma"

By Insights from 2023 ASCO® Annual Meeting FEATURING Kohei Shitara
By Insights from 2023 ASCO® Annual Meeting FEATURING Kohei Shitara
486 views
June 12, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Related Content

AUTOPLAY
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
27:12
Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta
07:35
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including…

Feat. R. Kim, R. Mehta
09:42
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "MATTERHORN & KEYNOTE-585 C…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
23:27
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…

Feat. R. Kim, R. Mehta
13:47
Sakti Chakrabarti

Neoadjuvant IO in MSI-High GI Cancers: Special Focus on the DREAM GI…

Feat. A. Shreenivas
18:51
Hope for Stomach Cancer

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Feat. D. Catenacci
16:53
Scripps MD Anderson Cancer Center

GC/GEJC/EC Trials - Evolving Landscape and Treatment Guidance

Feat. J. Hecht
10:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Randomized Phase 3 GASTFOX Study - 5-fluor…

Feat. A. Zaanan
03:31
ecancer

ESMO 2023 Summary: "Highlights From Recent GI Cancer Trials&quo…

Feat. B. Gyawali
23:26
Yale Cancer Center

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Feat. C. Balch
08:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 ATTRACTION-5 Study - Nivo + Chemo…

Feat. M. Terashima
20:44
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Upper GI Cancers"

Feat. S. Cytryn, F. Pietrantonio, G. Argiles Martinez
11:02
ASCO GI 2023 Conference Coverage

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

Feat. Y. Y. Janjigian
06:32
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "STAR-221 Phase 3 Trial - Domvanalimab, Zi…

Feat. S. Klempner
18:55
ImmunoTherapy Bridge 2023

Immunotherapy in GI Cancer: Current Treatment Landscape and Challeng…

Feat. A. Avallone
19:29
Total Health

Case-Based Clinical Updates in GI Cancer: 56 y/o Male With GEJ Adeno…

Feat. R. Mehta, M. Tejani, K. Blue
18:15
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Role of IO in Gastric Cancer"

Feat. S. Rha